Shanghai Protocell Medical Technology Co., Ltd
原启生物
Shanghai Protocell Medical Technology Co., Ltd
Biotech/Healthcare
Founded in 2015, OriGene Biotech is an innovative pharmaceutical company dedicated to developing tumor cell immunotherapy products through proprietary technology platforms. It has developed OriCAR-017, a GPRC5D CAR-T product for the treatment of relapsed/refractory multiple myeloma, and launched…
Latest round: IPO (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.